The effect of molnupiravir and nirmatrelvir on SARS-CoV-2 genome diversity in severe models of COVID-19 (2024)
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1101/2024.02.27.582110
PubMed Identifier: 38464327
Publication URI: http://europepmc.org/abstract/MED/38464327
Type: Preprint
ISSN: 2692-8205